{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T20:58:40Z","timestamp":1773521920786,"version":"3.50.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T00:00:00Z","timestamp":1646870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T00:00:00Z","timestamp":1646870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s15010-022-01790-2","type":"journal-article","created":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T17:04:50Z","timestamp":1646931890000},"page":"995-1000","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Pneumocystis in the era of prophylaxis: do the guidelines have to change?"],"prefix":"10.1007","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7265-6696","authenticated-orcid":false,"given":"Julien","family":"Nunes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nah\u00e9ma","family":"Issa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amandine","family":"Dupuis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Accoceberry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Pedeboscq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,10]]},"reference":[{"key":"1790_CR1","unstructured":"Nicolaides NC, Pavlaki AN, Alexandra MAM, Chrousos GP. Table 1: [Glucocorticoid equivalencies ()]. MDText.com, Inc., 2018. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK279156\/table\/adrenal_glucocorticoid-therapy-and-adrenal-suppression.T. Accessed 10 Jan 2022"},{"key":"1790_CR2","first-page":"e5071","volume":"11","author":"P Parajuli","year":"2019","unstructured":"Parajuli P, Ibrahim AM, Siddiqui HH, Lara Garcia OE, Regmi MR. Trimethoprim-sulfamethoxazole induced pancytopenia: a common occurrence but a rare diagnosis. Cureus. 2019;11:e5071.","journal-title":"Cureus"},{"key":"1790_CR3","doi-asserted-by":"publisher","first-page":"358","DOI":"10.3390\/clinpract11020050","volume":"11","author":"K Sawalha","year":"2021","unstructured":"Sawalha K, Sobash PT, Kamoga G-R. A rare cause of drug-induced pancytopenia: trimethoprim-sulfamethoxazole-induced pancytopenia. Clin Pract. 2021;11:358\u201362.","journal-title":"Clin Pract"},{"key":"1790_CR4","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1093\/ofid\/ofaa112","volume":"7","author":"G Butler-Laporte","year":"2020","unstructured":"Butler-Laporte G, Smyth E, Amar-Zifkin A, Cheng MP, McDonald EG, Lee TC. Low-dose TMP-SMX in the treatment of Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis. Open Forum Infect Dis. 2020;7:112.","journal-title":"Open Forum Infect Dis"},{"key":"1790_CR5","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1093\/jac\/dkw157","volume":"71","author":"J Maertens","year":"2016","unstructured":"Maertens J, Cesaro S, Maschmeyer G, et al. ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients. J Antimicrob Chemother. 2016;71:2397\u2013404.","journal-title":"J Antimicrob Chemother"},{"key":"1790_CR6","doi-asserted-by":"publisher","first-page":"e13587","DOI":"10.1111\/ctr.13587","volume":"33","author":"JA Fishman","year":"2019","unstructured":"Fishman JA, Gans H, AST Infectious Diseases Community of Practice. Pneumocystis jiroveci in solid organ transplantation: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33:e13587.","journal-title":"Clin Transplant"},{"key":"1790_CR7","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1111\/ijd.13231","volume":"55","author":"TM Gonzalez Santiago","year":"2016","unstructured":"Gonzalez Santiago TM, Wetter DA, Kalaaji AN, Limper AH, Lehman JS. Pneumocystis jiroveci pneumonia in patients treated with systemic immunosuppressive agents for dermatologic conditions: a systematic review with recommendations for prophylaxis. Int J Dermatol. 2016;55:823\u201330.","journal-title":"Int J Dermatol"},{"key":"1790_CR8","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.4065\/82.9.1052","volume":"82","author":"H Green","year":"2007","unstructured":"Green H, Paul M, Vidal L, Leibovici L. Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials. Mayo Clin Proc. 2007;82:1052\u20139.","journal-title":"Mayo Clin Proc"},{"key":"1790_CR9","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1136\/annrheumdis-2017-211796","volume":"77","author":"JW Park","year":"2018","unstructured":"Park JW, Curtis JR, Moon J, Song YW, Kim S, Lee EB. Prophylactic effect of trimethoprim-sulfamethoxazole for pneumocystis pneumonia in patients with rheumatic diseases exposed to prolonged high-dose glucocorticoids. Ann Rheum Dis. 2018;77:644\u20139.","journal-title":"Ann Rheum Dis"},{"key":"1790_CR10","doi-asserted-by":"publisher","first-page":"5093","DOI":"10.1182\/blood.V126.23.5093.5093","volume":"126","author":"K Ono","year":"2015","unstructured":"Ono K, Tsujimura H, Sugawara T, et al. Twice-weekly trimethoprim-sulfamethoxazole for the prevention of Pneumocystis jiroveci pneumonia in non-Hodgkin lymphoma patients. Blood. 2015;126:5093\u20135093.","journal-title":"Blood"},{"key":"1790_CR11","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1186\/s12879-019-3944-0","volume":"19","author":"GVR Prasad","year":"2019","unstructured":"Prasad GVR, Beckley J, Mathur M, et al. Safety and efficacy of prophylaxis for Pneumocystis jirovecii pneumonia involving trimethoprim-sulfamethoxazole dose reduction in kidney transplantation. BMC Infect Dis. 2019;19:311.","journal-title":"BMC Infect Dis"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-022-01790-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-022-01790-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-022-01790-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T08:22:11Z","timestamp":1659082931000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-022-01790-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,10]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["1790"],"URL":"https:\/\/doi.org\/10.1007\/s15010-022-01790-2","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,10]]},"assertion":[{"value":"22 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"As this retrospective study used anonymised healthcare data, patient consent was not required, in accordance with French legislation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate and consent to publish"}}]}}